Last edition
News about "Contract Development and Manufacturing Organizatio"
Samsung Biologics to Acquire PolyPeptide in All-Cash Deal
Samsung Biologics has launched a CHF 1.46 billion all-cash offer to acquire PolyPeptide, expanding its global CDMO network and multi-modality strategy.
Contract Development And Manufacturing Organizatio | 23/07/2026 | By News Bureau | 112
Cambrex Expands Snapdragon Chemistry Facility to Boost Peptide Therapy Manufacturing
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the expansion of its Snapdragon Chemistry API facility in Waltham, Massachusetts, strengthening its capabilities in peptide drug development and manufacturing.
Contract Development And Manufacturing Organizatio | 26/08/2025 | By Darshana | 218
Snapdragon Chemistry Expands Massachusetts Facility to Support Peptide Projects
Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts, by adding a new GMP manufacturing suite to strengthen the development and manufacturing of peptide therapies.
Contract Development And Manufacturing Organizatio | 25/08/2025 | By Dineshwori | 249
Akums Expands Analgesic Portfolio with New High-Concentration Paracetamol Oral Suspension
Akums Drugs and Pharmaceuticals has introduced Paracetamol Oral Suspension 500mg/5ml in the Indian market, strengthening its position in pain and fever management and adding a significant product to the analgesic and antipyretic category.
Contract Development And Manufacturing Organizatio | 22/07/2025 | By Dineshwori | 489
Oragenics, Sterling Pharma Solutions Ink Manufacturing Deal for Concussion Drug
Oragenics has partnered with Sterling Pharma Solutions for the GMP production of its lead drug candidate, ONP-002, for the treatment of concussion.
Contract Development And Manufacturing Organizatio | 18/07/2025 | By Dineshwori | 289
Granules India Expands into Peptide Therapeutics with Acquisition of Senn Chemicals
Senn Chemicals AG brings advanced expertise in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), along with an established customer base in pharmaceuticals, cosmetics, and theragnostic industries.
Contract Development And Manufacturing Organizatio | 24/02/2025 | By Aishwarya | 918
MedPharm Announces Merger with Tergus Pharma
MedPharm, Ltd. has announced a merger with Tergus Pharma, a Great Point Partners portfolio company.
Contract Development And Manufacturing Organizatio | 10/07/2024 | By Aishwarya | 781
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy